跳至主要内容
临床试验/ISRCTN10836802
ISRCTN10836802已完成未知

ong-term follow-up of patients with positive tests for HPV in 1990-1992, comparing HPV status at baseline with the risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) in the follow-up period of 30 years

niversity Hospital of North Norway0 个研究点目标入组 642 人开始时间: 2020年12月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
642

研究概览

简要总结

2021 results in https://pubmed.ncbi.nlm.nih.gov/34158090/ (added 24/06/2021)

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • All women referred to the HPV outpatient clinic at the University Hospital of Northern Norway (UNN) in 1990-1992, with an HPV test at baseline

排除标准

  • History of medical or surgical treatment for cervical cancer.

研究者

发起方
niversity Hospital of North Norway

相似试验

已完成
不适用
ong-term follow up of patients in European Vasculitis Study Group clinical trialsAnti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), granulomatosis with polyangiitis (GPA, Wegener’s granulomatosis (WG)) or microscopic polyangiitis (MPA)Circulatory SystemOther necrotizing vasculopathies
ISRCTN52952998Skane University Hospital Malmö-Lund, Sweden875
招募中
不适用
ong term follow up of the clinical and immunological responses following HPV 16 E6/E7 synthetic long peptides vaccination in women with HPV 16 positive vulvar intraepithelial neoplasia grade 3VINvulvair intraepithelial neoplasia10038594
NL-OMON36101eids Universitair Medisch Centrum19
已完成
不适用
Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) PatientsPatients Transplanted With NiCord/CordIn (Omidubicel)
NCT02039557Gamida Cell ltd33
进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864
EUCTR2016-000297-38-BEInstitut de Recherches Internationales Servier (I.R.I.S)200
进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864
EUCTR2016-000297-38-FRInstitut de Recherches Internationales Servier (I.R.I.S)200